3rd Quarter 2017 3rd Quarter 2016 Pe rfo rm an ce Group Revenues 7,109 5,256 Group EBITDA 843 516 Group Net Profit (Loss) 53 (164) HR C HRC Sales (k tons) 393 335 HRC Production Volume (k tons) 386 323
to dialysate unit business - one of the Company’s core businesses. This is expected to generate income and profit to the Company, then, makes the Company gain much more improved financial position and
subsidiaries for the three- month period ended March 31, 2018 and would like to clarify Q1/2018 operating results as follows: The consolidated net profit attributable to equity owners of the Company for the
the gain on disposal of investment in Ngam-Ngum 3 project for THB 14.56 million compared to THB 95.15 million in 2017. ▪ The THB 83.64-million-reversal of doubtful debt recorded in 2018 comes mainly
to Baht 19.41 million or 15.91% The other income went up 22.10% amount to Baht 18.15 million due to gain on sales of medical equipment amount to Baht 9.17 million. 2. The cost of medical treatments
Writer Ref. No. 066/2562 14 May 2019 SUBJECT : Management Discussion and Analysis ending 31 March 2019 ATTN : The President Stock Exchange of Thailand The Company realized profit for the first
. Profit (Loss) Net Equity of shareholders of the Company for Q2 / 2021 and Q2 / 2020 was 86.00 million baht and 50.11 million baht, respectively. It increase 35.89 million baht or 71.62% when compared with
security N/A 2 Net Operating Profit Criteria Cannot be calculated since disposed asset is not security N/A 3 Total Value of Consideration Criteria Total value of consideration x 100 / Total asset of the
increased because the unit sale price decrease as mentioned above. Also, Sweet corn price and can packaging price, which are major portion of costs, increased in year 2018. Gross profit The company has gross
1 Ref: CIG 003/2563 February 26, 2020 Subject: Profit and loss reporting for the year 2019 and explanation of more than 20 percent fluctuation in profit and loss compared to that of last year. To